American Journal of Obstetrics and Gynecology
Volume 172, Issue 4, Part 1, April 1995, Pages 1150-1157
An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy☆
References (17)
- et al.
Cervical dysplasia and human papillomavirus
Am J Obstet Gynecol
(1989) - et al.
Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study
Lancet
(1986) The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses
JAMA
(1989)Cervicography for evaluating the atypical Papanicolaou smear
J Reprod Med
(1991)- et al.
HPV screening for women with atypical Pap smears
J Reprod Med
(1991) - et al.
High rates of atypical cervical cytology: occurrence and clinical significance
Obstet Gynecol
(1992) - et al.
Behavior of mild cervical dysplasia during long-term follow-up
Obstet Gynecol
(1986) Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia
J Natl Cancer Inst
(1992)
There are more references available in the full text version of this article.
Cited by (137)
Preinvasive Disease of the Cervix
2012, Clinical Gynecologic Oncology: Eighth EditionScreening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study
2009, Annals of Diagnostic PathologyCitation Excerpt :However, in other study reporting the highest sensitivity, the positive predictive value ranged from 17.3% to 28.3% and the specificity from 24.2% to 66.8% [17]. In the study reported by Hatch et al [27], the sensitivity for predicting the presence of grade 2 or 3 CIN, in patients with Papanicolaou tests reported as LSIL, was found to be 76%. In patients with Papanicolaou tests reported as ASCUS, the sensitivity was 60%; specificity, 68%; and positive predictive value, 35%.
Preinvasive Disease of the Cervix
2007, Clinical Gynecologic OncologyHuman papillomavirus testing for triage of women referred because of abnormal smears: A decision analysis considering outcomes and costs
2002, Journal of Clinical EpidemiologyGenomics and proteomics: Application of novel technology to early detection and prevention of cancer
2002, Cancer Detection and Prevention
- ☆
Presented by invitation at the Thirteenth Annual Meeting of the American Gynecological and Obstetricial Society, Hot Springs, Virginia, September 8–10, 1994.
Copyright © 1995 Published by Mosby, Inc.